ACB $5.950 (-3.25%)

ACNNF $0.060 (-7.87%)

AERO $3.210 (0%)

ALEAF $0.238 (-0.95%)

AMMJ $0.128 (-0.31%)

APHA $15.380 (0%)

ARNA $60.080 (-1.64%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (65%)

AUSA:CNX $0.215 (0%)

AUSAF $0.166 (-3.39%)

AVXL $18.740 (-2.85%)

BAMM:CNX $0.590 (1.72%)

BBM:CNX $0.080 (-11.11%)

BBRRF $0.063 (-10.03%)

BE:CNX $0.005 (0%)

BIO:CNX $0.050 (0%)

BLEVF $0.002 (-6.25%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.870 (-1.14%)

BLOZF $0.686 (-3.34%)

BUDZ $0.300 (2.74%)

CADMF $0.140 (-0.71%)

CALI:CNX $0.080 (6.67%)

CANN $0.425 (0.93%)

CARA $15.930 (0.5%)

CBWTF $0.196 (-4.44%)

CGC $13.910 (-4.46%)

CGRW $0.085 (25.96%)

CHOO:CNX $0.055 (-8.33%)

CHOOF $0.045 (-2.81%)

CNBX $0.170 (2.16%)

CNGGF $0.196 (-6.51%)

CODI $27.610 (-3.9%)

CPMD $0.024 (-1.25%)

CRBP $1.040 (-5.45%)

CRON $5.700 (-5%)

CROP:CNX $0.015 (0%)

CRXPF $0.027 (-6.9%)

CSI:CNX $0.175 (0%)

CURR $0.748 (7.37%)

CVSI $0.260 (0.19%)

DIGP $0.043 (-10.42%)

DXBRF $0.075 (-0.53%)

EAT:CNX $0.115 (-11.54%)

EEVVF $0.162 (8.37%)

EMHTF $0.100 (-0.1%)

EPWCF $0.377 (0.9%)

EVIO $0.001 (-20%)

FFRMF $0.025 (-3.85%)

FFT:CNX $0.040 (0%)

FNNZF $0.061 (1.34%)

GNBT $0.201 (16.26%)

GRIN:CNX $0.175 (-2.78%)

GRWG $25.790 (-6.59%)

GTBIF $28.035 (4.51%)

GTII:CNX $35.490 (4.38%)

GWPH $218.960 (0%)

HEXO $1.910 (-2.05%)

HHPHF $0.187 (0%)

HLSPY $0.363 (0%)

HMLSF $6.250 (-2.59%)

HMPPF $0.498 (0%)

HRVOF $0.072 (5.86%)

HSTRF $0.194 (2.11%)

HUGE:CNX $1.950 (1.56%)

IAN:CNX $0.510 (-1.92%)

IGC $1.530 (-1.29%)

IGXT $0.430 (-2.11%)

IIPR $244.880 (-0.33%)

INQD $0.024 (-6.31%)

IONC:CNX $0.110 (46.67%)

IONKF $0.100 (63.4%)

ISOL:CNX $0.035 (0%)

ISOLF $0.030 (-15.49%)

ITHUF $0.400 (-2.44%)

IVITF $0.017 (-6.59%)

JWCAF $0.006 (-17.83%)

KALTF $0.246 (0.25%)

KBEV:CNX $0.065 (0%)

KBEVF $0.054 (8.78%)

KHRNF $0.222 (-1.77%)

KSHB $0.695 (0%)

LHS:CNX $1.470 (0%)

LHSIF $1.145 (0%)

LXX:CNX $8.400 (0%)

MCIG $0.028 (0%)

MEDIF $0.219 (-4.79%)

MGWFF $0.024 (-11.36%)

MJ:CNX $0.200 (5.26%)

MJNA $0.026 (-2.26%)

MNTR $0.106 (0%)

MRRCF $0.003 (8.7%)

MYM:CNX $0.140 (0%)

MYMMF $0.106 (0%)

NCNNF $0.058 (0%)

NDVAF $0.329 (-1.79%)

NGW:CNX $0.490 (1.03%)

NRXCF $0.071 (0%)

NSPDF $0.033 (1.36%)

NVTQF $0.702 (-0.92%)

NWKRF $0.424 (0%)

NXGWF $0.390 (0.26%)

NXTTF $0.099 (-4.4%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.001 (-76.32%)

PHCG $0.310 (-13.89%)

PHVAF $0.038 (0%)

PILL:CNX $0.720 (-2.7%)

PKG:CNX $0.100 (-9.09%)

PLPRF $0.357 (0%)

PLUS:CNX $0.440 (0%)

PMCB $3.300 (-2.65%)

POTN $0.001 (-9.09%)

PTNYF $0.079 (-13.98%)

QCA:CNX $0.180 (2.86%)

RDDTF $0.051 (1.1%)

RLLVF $0.012 (-27.04%)

RMHB $0.008 (-7.78%)

RQB:CNX $0.005 (0%)

RQHTF $0.640 (-5.86%)

RVVQF $0.001 (-30%)

SLNG:CNX $0.210 (5%)

SMG $144.850 (-0.79%)

SNN:CNX $0.155 (0%)

SNNVF $0.029 (45%)

SOL:CNX $3.790 (-0.52%)

SOLCF $2.990 (-0.72%)

SPRWF $0.268 (0%)

SRNA $0.060 (3.76%)

STEM:CNX $0.320 (3.23%)

STMH $0.259 (3.6%)

SUN:CNX $0.150 (0%)

TBPMF $0.201 (-0.4%)

TCAN:CNX $0.720 (-4%)

TCNAF $0.573 (-2.92%)

TER:CNX $9.010 (1.35%)

TGEN $1.810 (0.56%)

TGIF:CNX $0.080 (6.67%)

TGIFF $0.067 (12%)

THC:CNX $0.100 (0%)

THCBF $0.083 (7.34%)

TLRY $11.670 (-2.91%)

TOKI:CNX $0.020 (0%)

TRLFF $0.158 (5.07%)

TRSSF $7.126 (0.68%)

TURV $0.100 (33.33%)

VBIO $0.330 (-12.59%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.085 (0%)

VPRB $0.053 (0%)

VRT:CNX $0.450 (0%)

VVCIF $0.075 (-3.47%)

WAYL:CNX $0.740 (0%)

WLDFF $0.080 (5.12%)

XXII $2.970 (-4.19%)

ZDPY $0.860 (2.8%)

ZYNE $4.460 (-1.55%)

Technical420 Site Search

Returned 46 result(s).

Khiron Reports Q2 Results, 47% QoQ Increase in Medical Cannabis Revenues Driven by Colombia and Germany

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces its financial results for the quarter ended June 30, 2021. These filings are available for review on the Company's SEDAR profile at www.sedar.com. All financial information in this press release…

Khiron to Host Second Quarter 2021 Conference Call on August 23, 2021

Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF)(Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, today announces that it will host a conference call on Monday, August 23rd , 2021 at 10:00 a.m. Eastern Time to discuss its results…

3 Companies Effectively Leveraging ESG As A Key Focus Their Corporate Governance Strategy

One of the biggest themes of 2021 has centered around companies that have an environmental, social, and governance (ESG) component. So far this year, we have seen Wall Street banks and institutional investors really start to take ESG factors into account when investing or financing a business. According to ESG…

3 Companies To Evaluate When Looking At How To Play The South American Cannabis Market

So far, 2021 is proving to be a banner year for the Latin American cannabis market and this is a trend that we are closely following. The industry has benefited from being able to export cannabis and hemp products to the European Union (EU), in addition to Colombia offering insurance…

Khiron’s Colombian Clinic Business Is Helping Shape Key Features Of Its Rapidly Developing Medical Cannabis Market

Khiron Life Sciences Inc. (TSX Venture: KHRN) (OTC: KHRN) is a cannabis company that is flying under the radar and is one that we are closely following. The Latin American cannabis company is focused on improving people’s quality of life and we are favorable on how the management team has…

Colombia Expands Distribution of Medical Cannabis to Pharmacies Nationwide and Opens Export Market for Dried Flower Medical Cannabis

Khiron Life Sciences Corp. (TSXV: KHRN)(OTCQX: KHRNF)( Frankfurt : A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe , today announces its support for amendments to Colombia's medical cannabis decree, signed July 23, 2021 . With the enhanced regulations, Colombia continues to be a…

Khiron Life Sciences Robust Latin American Footprint Continues To Grow Like A Weed

2021 is proving to be a banner year for Khiron Life Sciences Corp. (TSXV: KHRN) (OTCMKTS: KHRNF) and this is a story that we are closely following. Specifically, we are impressed with how Khiron is capitalizing on emerging international markets in the European Union (EU) as well as in Latin…

Khiron Is Building Out A Robust Medical Cannabis Clinic Pipeline In One Of South America’s Most Underserved Markets

Last week, Khiron announced a major milestone and reported to have successfully completed its first sale of medical cannabis product in Brazil. By leveraging production, distribution, marketing agreements with leading pharmaceutical distributors, and clinical assets in Latin America, Khiron plans to expand its presence in Brazil. One of the reasons…

Khiron Life Sciences Comprehensive ESG Strategy Will Pay Dividends Going Into The Future

One of the most important trends in the cannabis sector is related to environmental, social, and governance (ESG) concerns. During the last month, we have seen a significant increase in the number of companies that are focused on addressing these concerns. Going forward, we expect the ESG trend to become…

Mexico Is Going To Become A Massive Growth Driver For Khiron Life Sciences As Both Medical and Adult Use Markets Continue To Mature

So far this year, the North American cannabis industry has recorded impressive advancements, and this is a trend that we are closely following. From a conservative US Supreme Court Justice calling cannabis regulation outdated to Mexico's Supreme Court decriminalizing recreational cannabis, we are favorable on the legalization trend and believe…

Older Posts »

Search Again